20.91MMarket Cap-1.45P/E (TTM)
1.200High1.080Low363.05KVolume1.190Open1.180Pre Close413.76KTurnover2.63%Turnover RatioLossP/E (Static)18.50MShares2.45052wk High3.91P/B15.62MFloat Cap0.76152wk Low--Dividend TTM13.82MShs Float9.590Historical High--Div YieldTTM10.17%Amplitude0.761Historical Low1.139Avg Price1Lot Size
Inspira Technologies Oxy Stock Forum
PR Newswire· 3 mins ago
RA'ANANA, Israel, Dec. 16, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN, IINNW), ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking respiratory support technology company, announced the delivery of INSPIRA ART100 systems to its U.S. distributor, Glo-Med Networks Inc ("Glo-Med"). The systems were shipped i...
Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment
Monday, 16th December at 8:30 am
RA'ANANA, Israel, Dec. 16, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN, IINNW)), ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking respiratory support technology company, announced the delivery of INSPIRA™ ART100 systems to its U.S. distributor, Glo-Med Networks Inc ("Glo-Med"). The systems wer...
1 min ago
Inspira™ Expands Hyla™ Blood Sensor Technology Into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions
Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions
Tuesday, 10th December at 8:00 am
RA'ANANA, Israel, Dec. 10, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN, IINNW)), ("Inspira Technologies" or the "Company"), a groundbreaking life support technology company, revealed the expansion of its HYLA blood sensor technology ("HYLA") into an immediate pers...
Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios
Inspira Technologies has established a strategic collaboration with Westchester Medical Centerin New York to evaluate the performance of its FDA-cleared INSPIRA ART100 systems in clinical scenarios. The partnership aims to expose Inspira's technology to leading physicians and medical institutions.
The co...
No comment yet